Free Trial

Tvardi Therapeutics (TVRD) Earnings Date, Estimates & Call Transcripts

Tvardi Therapeutics logo
$28.05 +1.40 (+5.25%)
As of 08/22/2025 04:00 PM Eastern

Tvardi Therapeutics Earnings Summary

Tvardi Therapeutics announced Q2 2025 earnings on August 14, 2025, reporting an EPS of -$1.00, which missed the consensus estimate of -$0.51 by $0.49. Tvardi Therapeutics currently has a trailing EPS of $0.00

Q2 2025 Earnings Resources

Consensus EPS
(Aug. 14)
-$0.51
Actual EPS
(Aug. 14)
-$1.00 Missed By -$0.49
Get Tvardi Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tvardi Therapeutics and other key companies, straight to your inbox.

Sign Up

Tvardi Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025-$0.51-$1.00 -$0.49-$1.00--


This page (NASDAQ:TVRD) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners